Mesenchymal Stem Cells for the Treatment of Skin Diseases

AIMS Cell and Tissue Engineering

Toshio Hasegawa¹ 

[1] Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan

关键词: mesenchymal stem cells;    adipose tissue-derived mesenchymal stem cell;    skin regeneration;    vitiligo;    alopecia;    epidermolysis bullosa;    anti-aging;    epidermal stem cells;    keratinocytes;    skin disease;   

DOI  :  10.3934/celltissue.2017.2.104

学科分类：医学（综合）

来源: AIMS Press

【 摘 要 】

Mesenchymal stem cell (MSC)-based therapy involving both autologous and allogeneic MSCs shows great promise in treating several conditions. MSCs promote wound healing, and can differentiate into multiple cell lineages, including keratinocytes. Therefore, MSCs can be used for the treatment of congenital or acquired skin defects. Because of their immunomodulatory properties, MSCs may be useful for the treatment of inflammatory and autoimmune skin diseases. In particular, MSCs might be effective for the treatment of large vitiligo lesions as immunosuppressant or cultured grafts. MSCs can also be a novel cell source for regenerating hair in the treatment of scarring alopecia and androgenic alopecia. MSCs might also be an effective treatment for alopecia areata, which is associated with autoimmunity. Stem cell therapies with topical administration of MSCs and bone marrow transplantation were shown to alleviate recessive dystrophic epidermolysis bullosa in both animal models and human subjects. In addition to cell transplantation, the mobilization of endogenous MSCs has been attempted for skin regeneration. Overall, this review highlights the great potential of MSCs for the treatment of skin diseases in the near future.

【 授权许可】

CC BY